La Jolla, Calif.; Seoul, Korea; and Singapore From the Division of Ophthalmic Plastic and Reconstructive Surgery, University of California, San Diego Department of Ophthalmology, Shiley Eye Center; the Division of Ophthalmic Plastic and Reconstructive Surgery, Department of Ophthalmology, Kim's Eye Hospital; and the Singapore National Eye Center.
Plast Reconstr Surg. 2011 Feb;127(2):844-849. doi: 10.1097/PRS.0b013e3181fed6cb.
Preliminary experience with the use of hyaluronic acid fillers as a nonsurgical alternative in the management of upper eyelid crease asymmetry and superior sulcus hollowing in Asian patients has proven promising.
This retrospective, interventional case series included seven patients (11 eyes) of various Asian ancestries. All patients had eyelid crease asymmetry or undesirably elevated eyelid creases along with hollowing of the upper eyelids. Upper eyelid crease asymmetry and hollowing of the superior sulcus were assessed before and after treatment. For all patients, hyaluronic acid fillers (Restylane, Medicis, Scottsdale, Ariz., or Juvéderm, Allergan, Irvine, Calif.) were injected into the retro-septal superior sulcus for eyelid hollowing and into the preseptal eyelid fold for crease asymmetry. Pretreatment and posttreatment photographs were taken. Outcomes were assessed by the total volume injected; masked, independent assessment using preoperative and postoperative photographs; and the subjective assessment of results by the patient.
The average age was 43.1 years. The average volume of hyaluronic acid filler injected was 0.61 cc per eye. All seven patients were satisfied with the cosmetic improvement after hyaluronic acid filler injections. No adverse effects were noted. To date, the treatment has remained effective for as long as 18 months.
Hyaluronic acid filler injections into the upper eyelid and superior sulcus are effective in providing volume to recreate the fullness natively present in the Asian upper eyelid. Furthermore, this fullness lowers the surgically created eyelid crease in those patients with eyelid asymmetry following cosmetic blepharoplasty. It should be considered in Asian patients presenting with upper eyelid hollowing or asymmetric eyelid creases.
在亚洲患者中,使用透明质酸填充剂作为非手术替代方法来改善上睑折痕不对称和上睑眶下凹陷的初步经验已被证明是有希望的。
本回顾性、介入性病例系列研究纳入了 7 名(11 只眼)不同亚洲血统的患者。所有患者均存在上睑折痕不对称或上睑折痕过高,以及上睑凹陷。在治疗前后评估上睑折痕不对称和上睑眶下凹陷。所有患者均在上睑眶下的后隔内注射透明质酸填充剂(瑞蓝,Medicis,斯科茨代尔,亚利桑那州或乔雅登,Allergan,尔湾,加利福尼亚州)以填充上睑凹陷,并在上睑褶皱前注射以矫正折痕不对称。术前和术后均拍摄照片。通过注射的总容量、术前和术后照片的盲法、独立评估以及患者对结果的主观评估来评估结果。
平均年龄为 43.1 岁。每只眼平均注射透明质酸填充剂 0.61 毫升。所有 7 名患者均对透明质酸填充剂注射后的美容改善效果满意。未观察到不良反应。到目前为止,治疗效果最长可维持 18 个月。
在上睑和上睑眶下注射透明质酸填充剂可有效提供体积,以重现亚洲人上睑原有的丰满度。此外,对于接受美容性上睑成形术后出现上睑不对称的患者,这种丰满度可降低手术形成的上睑折痕。对于出现上睑凹陷或上睑折痕不对称的亚洲患者,应考虑采用这种方法。